BioLargo, Inc. (BLGO)
OTCQB OTCQB Primary 
BioLargo Achieves Record Quarterly Revenue of $5 Million for Second Quarter of 2024
Q2 2024 revenues grew 247% compared to same three months last year WESTMINSTER, CA / ACCESSWIRE / August 6, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced preliminary results for its second quarter ended June 30, 2024: Companywide revenue ($5.0 million) for the quarter increased 247% compared with the second quarter of 2023 and increased 5% compared to the first quarter of 2024 (revenues for the six months ended June 30, 2024, increased 88% over the first six months of 2023). The company had a net loss for the quarter of $780,000, which included approximately $540,000 in non-cash stock option compensation expense.
BioLargo Engineering Increases Ongoing Revenue with Another Air Force Contract
USAF work now amounts to over $100,000 in revenue per month. WESTMINSTER, CA / ACCESSWIRE / June 20, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that its engineering subsidiary has been awarded a subcontract to provide air quality services to two Arizona U.S. Air Force bases for up to four years, with expected annual revenue of approximately $812,000.
BioLargo Subsidiary Clyra Medical Selects Keystone Industries to Support Manufacturing of its Medical Products
WESTMINSTER, CA / ACCESSWIRE / June 12, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that its subsidiary Clyra Medical Technologies, Inc. ("Clyra") has selected Keystone Industries, a global manufacturer of medical, dental and cosmetic products with distribution partners in more than 70 countries, to support manufacturing of its medical products. The relationship focuses on the build-out of scaled manufacturing capacity for Clyra's FDA 510(k) cleared Bioclynse surgical wound irrigation solution.
BioLargo Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion
WESTMINSTER, CA / ACCESSWIRE / June 11, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that it had succeeded in manufacturing its first CellinityTM "Liquid Sodium" prototype battery cells. Visit www.BioLargoEnergy.com to learn more.
BioLargo Engineering Secures Multi-Year Air Force Base Air Compliance Project
WESTMINSTER, CA / ACCESSWIRE / June 7, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that its engineering subsidiary has been awarded a contract to provide air quality services to three New Mexico U.S. Air Force (USAF) bases for up to five years, with a potential annual average revenue of $650,000. The new contract is in addition to ongoing environmental support work at six Air Force bases and is the company's largest dollar-value Air Force contract to date.
